Yahoo · Sep 15, 2026
Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial Results
Vera Therapeutics takes a step toward securing full Food and Drug Administration approval for its injectable kidney drug, Trutakna.
OT
NYSE · OTSKY
Otsuka Holdings Co., Ltd.
Healthcare · Drug Manufacturers - General
$35.36
Down-$0.64 (-1.76%)
Updated Sep 20, 2026, 4:43 AM
SID Score
6.0/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 32.85B
- P/E ratio
- 10.98
- Dividend yield
- 1.23%
- 52-week range
- — – —
- Volume
- 633
- Avg. volume
- 37.4K
Price performance
OTSKY price history
1M range · 0 trading sessions · Daily adjusted prices
OTSKY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest OTSKY news
The latest Smart Investors Daily articles mentioning OTSKY.
Stock researchResearch & News · News
Loading stock research…